Leading pharmaceutical companies have seen their combined market capitalizations increase by more than $50 billion in 2020 as they scramble to develop a vaccine for the coronavirus, according toGilead Sciences is the frontrunner among six pharma companies, seeing a $15.7 billion gain in market value, helped by its trials of the antiviral medication Remdesivir.
Gilead came out as the top winner in market value and shot to the public spotlight during the pandemic, seeing about a $15.7 billion increase in the period. Moderna, one of the companies furthest along in its vaccine development, has seen its market value jump by $15.5 billion amid the coronavirus outbreak.
On May 18, the company's market capitalization peaked at $28.3 billion as its stock climbed after receiving a financial boost of $483 million from US agency Biomedical Advanced Research and Development Authority to spur development of a vaccine.British drugmaker AstraZeneca saw a $12.2 billion increase in market value in the same period.
Here’s one of those giants that would rather take vs give back to better American communities; for the common good of all! Fed & Local government can change the process by creating guidelines that eliminate Corporate lobby quid pro quo💰in exchange for political favors!
Probably the same pharmaceutical companies that pedaled opiates to America, they are the real criminals but get a pass from the government
This is what the virus is about ... This is why they tried to discredit HCQ
Rrriiiiight